Yeah it’s the trials that are really expensive, not the basic research. The government gets to spread its dollars around to lots of individual researchers but if they were instead using that money to fund phase III trials (1) we’d have a lot a lot less money for basic research (2) we’d fund a lot fewer phase III trials so (3) we’d see much less drug development overall. Also I’d worry about a potential conflict of interest if the same government is conducting and evaluating the results of drug trials.
No comments yet.